Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hildebrandt

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Drug Discovery Today|October 20, 2019
Horses for courses: an approach to the qualification of clinical trial sites and investigators in ATMPsMartin Hildebrandt
Cytotherapy|September 3, 2013
Joint conference on the impact of EU legislation on therapeutic advanceNikolaus Forgó, Martin Hildebrandt
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
SDF-1 (CXCL12) in haematopoiesis and leukaemia: impact of DPP IV/CD26Martin Hildebrandt, Richard Schabath
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|July 11, 2022
Advanced Therapy Medicinal Products and the Changing Role of AcademiaChristoph Priesner, Martin Hildebrandt
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|June 27, 2009
[Conflicts of interest and clinical drug trials -- impact of the pharmaceutical industry and the impingement on the integrity of medical science]Wolf-Dieter Ludwig, Martin Hildebrandt, Gisela Schott
Advances in Experimental Medicine and Biology|May 17, 2006
DPIV/CD26 and FAP in cancer: a tale of contradictionsMelanie L Sulda, Catherine A Abbott, Martin Hildebrandt
Advances in Experimental Medicine and Biology|April 5, 2003
DPP IV, immune parameters, and psychometrical variables in patients with eating disordersHerbert Fliege, Matthias Rose, Burghard F Klapp, et al.
Diabetes Care|January 5, 2002
The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic controlMatthias Rose, Herbert Fliege, Martin Hildebrandt, et al.
Deutsche Medizinische Wochenschrift (1946)|July 13, 2021
[Update 2021: COVID-19 from the Perspective of Haematology and Haemostaseology]Karsten Spiekermann, Marion Subklewe, Martin Hildebrandt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 13, 2019
Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case studyKonrad Kokowski, Stefan Stangl, Sophie Seier, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Drug Discovery Today|October 20, 2019
Horses for courses: an approach to the qualification of clinical trial sites and investigators in ATMPsMartin Hildebrandt
Cytotherapy|September 3, 2013
Joint conference on the impact of EU legislation on therapeutic advanceNikolaus Forgó, Martin Hildebrandt
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
SDF-1 (CXCL12) in haematopoiesis and leukaemia: impact of DPP IV/CD26Martin Hildebrandt, Richard Schabath
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|July 11, 2022
Advanced Therapy Medicinal Products and the Changing Role of AcademiaChristoph Priesner, Martin Hildebrandt
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|June 27, 2009
[Conflicts of interest and clinical drug trials -- impact of the pharmaceutical industry and the impingement on the integrity of medical science]Wolf-Dieter Ludwig, Martin Hildebrandt, Gisela Schott
Advances in Experimental Medicine and Biology|May 17, 2006
DPIV/CD26 and FAP in cancer: a tale of contradictionsMelanie L Sulda, Catherine A Abbott, Martin Hildebrandt
Advances in Experimental Medicine and Biology|April 5, 2003
DPP IV, immune parameters, and psychometrical variables in patients with eating disordersHerbert Fliege, Matthias Rose, Burghard F Klapp, et al.
Diabetes Care|January 5, 2002
The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic controlMatthias Rose, Herbert Fliege, Martin Hildebrandt, et al.
Deutsche Medizinische Wochenschrift (1946)|July 13, 2021
[Update 2021: COVID-19 from the Perspective of Haematology and Haemostaseology]Karsten Spiekermann, Marion Subklewe, Martin Hildebrandt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 13, 2019
Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case studyKonrad Kokowski, Stefan Stangl, Sophie Seier, et al.
Pageof 5